Division of Plastic Surgery, Mayo Clinic, Jacksonville, FL, U.S.A.
Department of Surgery, Mayo Clinic, Jacksonville, FL, U.S.A.
Anticancer Res. 2019 Nov;39(11):6359-6363. doi: 10.21873/anticanres.13848.
BACKGROUND/AIM: To analyze whether demographic and facility type characteristics cause inequality in the type of biopsy performed in patients with cutaneous melanoma.
The skin cancer National Cancer Database was assessed. Men and women of all ages with cutaneous melanoma in situ and malignant melanoma at any stage of the disease were included. Patients were selected who underwent one of the following biopsy types: excisional, punch, shave, or incisional. Bivariate and multivariate analyses were performed.
We found that the likelihood of undergoing an excisional biopsy decreased in patients who were: Hispanic [odds ratio (OR)=0.63, confidence interval (CI)=0.55-0.71], non-White (OR=0.66, CI=0.58-0.76), older than 80 years (OR=0.77, CI=0.72-0.87), or in Comprehensive Community Cancer Programs (OR=0.33, CI=0.31-0.36), Community Cancer Programs (OR=0.52, CI=0.50-0.54) and Integrated Network Cancer Programs (OR=0.58, CI=0.55-0.61).
Our study results demonstrate disparities in biopsy type in the treatment of melanoma.
背景/目的：分析人口统计学和医疗机构类型特征是否导致皮肤黑色素瘤患者活检类型的不平等。
评估皮肤癌国家癌症数据库。纳入所有年龄段的原位皮肤黑色素瘤和任何疾病阶段的恶性黑色素瘤的男性和女性患者。选择接受以下活检类型之一的患者：切除活检、打孔活检、刮除活检或切开活检。进行了双变量和多变量分析。
我们发现，接受切除活检的可能性降低的患者包括：西班牙裔（优势比[OR]=0.63，置信区间[CI]=0.55-0.71）、非白种人（OR=0.66，CI=0.58-0.76）、80 岁以上（OR=0.77，CI=0.72-0.87）、综合社区癌症计划（OR=0.33，CI=0.31-0.36）、社区癌症计划（OR=0.52，CI=0.50-0.54）和综合网络癌症计划（OR=0.58，CI=0.55-0.61）。
我们的研究结果表明，在黑色素瘤治疗中存在活检类型的差异。
